Accelerator Entry: REOFTech accepted into Gen.1 of BioLeap and EC-Safety accepted into Pre18
The company was accepted into two accelerator programs within Puerto Rico.
Publication: Oscillometric blood pressure measurements on smartphones using vibrometric force estimation
Authors: Colin Barry, Yinan Xuan, Ava Fascetti, Alison Moore, Edward J Wang Abstract This paper proposes a smartphone-based method for measuring Blood Pressure (BP) using the oscillometric method. For oscillometry, it is necessary to measure (1) the pressure applied to the artery and (2) the local blood volume change. This is accomplished by performing an oscillometric measurement at the finger's digital artery, whereby a user presses down on the phone's camera with steadily increasing force. The camera is used to capture the blood volume change using photoplethysmography. We devised a novel method for measuring the force applied of the finger without the use of specialized smartphone hardware with a technique called Vibrometric Force Estimation (VFE). The fundamental concept of VFE relies on a phenomenon where a vibrating object is dampened when an external force is…
Oral Presentation: NIA workshop – Leveraging Adaptive Technology (“Just-in-Time”) Interventions for Aging and Alzheimer’s Disease and Alzheimer’s Disease-related Dementias
Dr. Inbal Billie Nahum-Shani (PI) presented work from this pilot project during a talk titled "Adaptive interventions and JITAIs as decision policies: What and why?" as part of Session 1 - Digital adaptive interventions: decision-focused evidence production held on October 16, 2024. Source: NIA Event Page
Grant Funding: NIA R01 (R01AG089169)
Title: Neural mechanisms of gait disturbances as individualized digital biomarker trajectories in preclinical dementia Public Health Relevance Statement: In this project, the research team uncovers the neural mechanisms of gait and mobility disturbances in preclinical dementia and identifies trackable individualized digital biomarkers (from videos). They evaluate the specificity and sensitivity of these gait-based biomarkers and relate those to neural mechanisms and clinical phenotypes. By leveraging these identified markers, they can monitor the disease's progression, potentially minimizing or even replacing the demand for expensive neuropsychological or neuroimaging evaluations. Source: R01AG089169 (NIH RePORTER)
Award: Don Norman Design Award 2024 – Special Recognition
Billion Labs Inc was honored with a DNDA24 Special Recognition for "Reducing Barrier to Access Hypertension Screening Globally." What they said: Billion Labs Inc. is a startup company whose mission is to transform the billions of smartphones in everyone’s pocket to screen for critical health conditions like all-cause mortality, hypertension, diabetes, and more with nothing but a download of an app, making health monitoring affordable and accessible to everyone. Their solution, Vibro, is a smartphone app that requires no extra devices to measure blood pressure. The ultimate goal is to provide affordable blood pressure monitoring by leveraging the existing smartphone infrastructure. Even if an individual does not own a smartphone personally, access can be bootstrapped through family and community support, reducing barriers of accessing hypertension screening. Through iterative design process, the team continues to refine…
Grant Funding: NIA SBIR Phase I (R43AG090129)
Title: AVA AI Video-Based Mobile Application for Reliable, Accessible, and Low-Cost Fall Risk Assessments of Older Adults Public Health Relevance Statement: This project presents AVA, a video-based mobile app for at-home fall risk assessment of older adults, only using a smartphone to enable a much higher access, low-cost solution with full privacy protection. AVA empowers caregivers to assess the gait, balance, and strength of their older adults independently without the direct supervision of healthcare professionals. The Phase I study focuses on validating AVA's AI-based assessment technology and its usability in diverse home and independent living settings which can lead to revolutionizing current fall risk assessment practices. Source: R43AG090129 (NIH RePORTER)
Grant Funding: 2024 Innovation Award Competition: Center for Advancing Point of Care Technologies in Heart, Lung, Blood and Sleep Disorders (CAPCaT)
Billion Labs Inc is a recipient of the 2024 CAPCaT Innovation Award to further advance the design of the user interface for their VibroBP smartphone app for measuring blood pressure. The award covers $100,000 in direct costs for the 12-month long project. The CAPCaT is a partnership between UMass Chan Medical School and UMass Lowell. The center's mission is to support development and testing of promising, point-of-care technologies that can be rapidly deployed to enhance the diagnosis, monitoring, management and treatment of heart, lung, blood and sleep disorders. The center has an additional interest in projects that incorporate complementary and integrative health approaches. CAPCaT is supported by the National Heart, Lung, and Blood Institute via U54HL143541. Source: https://www.universityofcalifornia.edu/news/blood-pressure-readings-your-fingertips (Press Release)